期刊
THERANOSTICS
卷 8, 期 21, 页码 5986-5994出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.26650
关键词
Exosome; EphA2; Cytotoxic resistance; Pancreatic cancer; Gemcitabine
资金
- NIH [U01CA214254, R01HD090927, R01AI122932, R01AI113725, R21Al126361-01, 5P50CA126752-08]
- Arizona Biomedical Research Commission (ABRC) young investigator award
- Fred Hutchinson Cancer Research Center [0000917241]
- NIH
- PANCAN-AACR Career Development Award [14-20-25-KOAY]
- Radiological Society of North America seed grant [RSD1429]
- National Natural Science Foundation of China [81702996]
- Shiekh Ahmed Center for Pancreatic Cancer Research at The University of Texas M.D. Anderson Cancer Center
- Center for Radiation Oncology Research at The University of Texas M.D. Anderson Cancer Center
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD090927] Funding Source: NIH RePORTER
- NATIONAL CANCER INSTITUTE [P50CA126752, U01CA214254] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI122932, R01AI113725] Funding Source: NIH RePORTER
Rationale: Exosomes are small extracellular vesicles secreted by most cells that are found in blood and other bodily fluids, and which contain cytoplasmic material and membrane factors corresponding to their cell type of origin. Exosome membrane factors and contents have been reported to alter adjacent and distant cell behavior in multiple studies, but the impact of cancer-derived exosomes on chemoresistance is less clear. Methods: Exosomes isolated from three pancreatic cancer (PC) cell lines displaying variable gemcitabine (GEM) resistance (PANC-1, MIA PaCa-2, and BxPC-3) were tested for their capacity to transmit chemoresistance among these cell lines. Comparative proteomics was performed to identify key exosomal proteins that conferred chemoresistance. Cell survival was assessed in GEM responsive PC cell lines treated with recombinant Ephrin type-A receptor 2 (EphA2), a candidate chemoresistance transfer factor, or exosomes from a chemoresistant PC cell line treated with or without EphA2 shRNA. Results: Exosomes from chemoresistant PANC-1 cells increased the GEM resistance of MIA PaCa-2 and BxPC-3 cell cultures. Comparative proteomics determined that PANC-1 exosomes overexpressed Ephrin type-A receptor 2 (EphA2) versus exosomes of less chemoresistant PC cell lines MIA PaCa-2 and BxPC-3. EphA2-knockdown in PANC-1 cells inhibited their ability to transmit exosome-mediated chemoresistance to MIA PaCa-2 and BxPC-3, while treatment of MIA PaCa-2 and BxPC-3 cells with soluble EphA2 did not promote chemoresistance, indicating that membrane carried EphA2 was important for the EphA2 chemoresistance effect. Conclusion: Exosomal EphA2 expression could transmit chemoresistance and may potentially serve as a minimally-invasive predictive biomarker for PC treatment response. Further work should address whether additional exosomal factors regulate resistance to other cancer therapeutic agents for PC or other cancer types.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据